Research
Hormonal
The oral formulation of semaglutide reduced AF incidence by 52%.
The oral formulation of semaglutide may be particularly effective in reducing AF risk.
StrongSupportsmedium confidence
The effect was more pronounced with the oral formulation, which reduced AF incidence by 52% (OR 0.48, 95% CI 0.24-0.95, p = 0.04).
Why this rating
Derived from a meta-analysis of multiple RCTs.
Source
Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials
Arturo Cesaro et al. · European Journal of Preventive Cardiology · 2025
Meta-analysisCited 29×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →